Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Premier Inc. Creates Oncology-Focused Purchasing Alliance with 20 Leading Cancer Providers to Source Branded Cancer Drugs
Premier Inc. Creates Oncology-Focused Purchasing Alliance with 20 Leading Cancer Providers to Source Branded Cancer Drugs


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today debuted Intersectta®, a new oncology-focused group purchasing organization (GPO) to source cancer and other specialty

Acadia Healthcare Announces Pricing of $450 Million Senior Notes Due 2028 and Intention to Redeem Its 2021 Notes and 2022 Notes
Acadia Healthcare Announces Pricing of $450 Million Senior Notes Due 2028 and Intention to Redeem Its 2021 Notes and 2022 Notes


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today the pricing of its previously announced private offering (the “Offering”) of $450 million in aggregate

Acadia Healthcare Announces Launch of $450 Million Senior Notes Offering
Acadia Healthcare Announces Launch of $450 Million Senior Notes Offering


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today that it has launched a private offering (the “Offering”) of senior notes due 2028 (the “Notes”), subject

Premier Inc. Recommends 24 Regulatory Waivers Be Made Permanent After COVID-19
Premier Inc. Recommends 24 Regulatory Waivers Be Made Permanent After COVID-19


Premier Inc. (NASDAQ: PINC) today provided the U.S. Department of Health and Human Services (HHS) and Congress with a list of 24 regulatory waivers that should be made permanent as the COVID-19

HemaCare Adds GMPrimeTM Cryopreserved Leukopak to its GMP Product Portfolio
HemaCare Adds GMPrimeTM Cryopreserved Leukopak to its GMP Product Portfolio


HemaCare Corporation, a Charles River Laboratories International, Inc. (NYSE:CRL) company and global leader and trusted brand in the customization of human-derived biological products and services

Novocure Announces Launch of MyLink™ to Enable Patient-Guided, Remote Download of Optune® Usage Data
Novocure Announces Launch of MyLink™ to Enable Patient-Guided, Remote Download of Optune® Usage Data


Novocure (NASDAQ: NVCR) today announced the launch of MyLink, a new tool that allows patients to download their Optune usage data from the comfort of home without the need for an in-person visit by

Charles River Laboratories to Participate in Jefferies and William Blair Conferences
Charles River Laboratories to Participate in Jefferies and William Blair Conferences


Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at the Jefferies Virtual Healthcare Conference on Tuesday, June 2nd, at 10:00 a.m. ET, and

Acadia Healthcare to Participate in Jefferies Virtual Global Healthcare Conference 2020
Acadia Healthcare to Participate in Jefferies Virtual Global Healthcare Conference 2020


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the Jefferies Virtual Global Healthcare Conference 2020, which takes place June 2 – 4, 2020

Premier Inc. ProvideGx™ Program Partners with Hikma Pharmaceuticals to Secure the Supply of Two Drugs Essential for COVID-19 Patient Care
Premier Inc. ProvideGx™ Program Partners with Hikma Pharmaceuticals to Secure the Supply of Two Drugs Essential for COVID-19 Patient Care


Premier Inc. (NASDAQ: PINC), through its ProvideGx™ program, has partnered with Hikma Pharmaceuticals PLC (Hikma, Group) to supply amiodarone and sterile water to healthcare providers, helping to

Chemed Corporation to Present at the Jefferies 2020 Virtual Healthcare Conference
Chemed Corporation to Present at the Jefferies 2020 Virtual Healthcare Conference


Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Jefferies 2020 Virtual Healthcare Conference on Thursday, June 4, 2020, at approximately 9:00 a.m. (ET).

Xencor to Present at Upcoming Investor Conferences
Xencor to Present at Upcoming Investor Conferences


Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced that Bassil

Premier Inc. and 15 Leading Health Systems Invest to Expand Domestic PPE Production Through Prestige Ameritech
Premier Inc. and 15 Leading Health Systems Invest to Expand Domestic PPE Production Through Prestige Ameritech


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, and 15 leading health systems acquired a minority stake in Prestige Ameritech, the largest domestic manufacturer of face

Premier Inc. Launches New Program to Invest in Domestic and Diverse Manufacturing Capabilities
Premier Inc. Launches New Program to Invest in Domestic and Diverse Manufacturing Capabilities


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today announced a new program to invest in domestic and geographically diverse manufacturers to ensure a robust and resilient

Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend


Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company’s 2020 annual stockholders’ meeting. New to the Board are Ron DeLyons, 58, Managing Member and

Xencor to Present Data from Four Preclinical XmAb® 2+1 Bispecific Antibody and Cytokine Programs at AACR Virtual Annual Meeting II
Xencor to Present Data from Four Preclinical XmAb® 2+1 Bispecific Antibody and Cytokine Programs at AACR Virtual Annual Meeting II


Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced it will

Acadia Healthcare to Participate in the UBS Virtual Global Healthcare Conference and the RBC Capital Markets Global Healthcare Virtual Conference
Acadia Healthcare to Participate in the UBS Virtual Global Healthcare Conference and the RBC Capital Markets Global Healthcare Virtual Conference


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in two upcoming virtual healthcare conferences.



On Tuesday, May 19, 2020, the Company will present

Xencor Reports Initial Dose-Escalation Data from Phase 1 Study of XmAb®20717, PD-1 x CTLA-4 Bispecific Antibody, in Solid Tumors
Xencor Reports Initial Dose-Escalation Data from Phase 1 Study of XmAb®20717, PD-1 x CTLA-4 Bispecific Antibody, in Solid Tumors


Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today reported initial

Premier Inc. Survey: Clinically Integrated Networks in Alternative Payment Models Expanded Value-Based Care Capabilities to Manage COVID-19 Surge
Premier Inc. Survey: Clinically Integrated Networks in Alternative Payment Models Expanded Value-Based Care Capabilities to Manage COVID-19 Surge


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released survey results finding that participants in alternative payment models (APMs) have drawn heavily on their

China NMPA Approves Optune® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
China NMPA Approves Optune® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma


Novocure (NASDAQ: NVCR), a global oncology company with a proprietary platform therapy called Tumor Treating Fields, and Zai Lab Limited (NASDAQ: ZLAB), an innovative commercial stage

Xencor to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference
Xencor to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference


Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced that Bassil

Molina Healthcare of Ohio Commits $1.5 Million to Advance the Health of Ohioans Through its 2020 Community Innovation Fund
Molina Healthcare of Ohio Commits $1.5 Million to Advance the Health of Ohioans Through its 2020 Community Innovation Fund


Molina Healthcare of Ohio (“Molina”) is dedicated to building healthier communities and is committing over $1.5 million to support innovative programs across Ohio.



The Molina Community Innovation

Acadia Healthcare to Participate in BofA Securities 2020 Health Care Conference
Acadia Healthcare to Participate in BofA Securities 2020 Health Care Conference


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the BofA Securities 2020 Health Care Conference, which takes place May 12 – 14, 2020. This

Premier Inc. Predictive Technology Helps Prepare for Resumption of Elective Procedures by Identifying Surges in COVID-19 Cases and Supply Needs
Premier Inc. Predictive Technology Helps Prepare for Resumption of Elective Procedures by Identifying Surges in COVID-19 Cases and Supply Needs


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, is leveraging its technology solutions to help hospitals and health systems across the country anticipate surges in COVID-19

Xencor Reports First Quarter 2020 Financial Results
Xencor Reports First Quarter 2020 Financial Results


Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today reported financial

Premier Inc. Survey: Hospitals’ COVID-19 Testing Capacity Must at Least Triple Before Elective Surgeries Can Fully Resume
Premier Inc. Survey: Hospitals’ COVID-19 Testing Capacity Must at Least Triple Before Elective Surgeries Can Fully Resume


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released new survey results finding that healthcare facilities need to expand their current COVID-19 testing capacity by